Author: Barkas, Fotios; Anastasiou, Georgia; Milionis, Haralampos; Liberopoulos, Evangelos
Title: Sodium-glucose cotransporter inhibitors may reduce the risk of pneumonia: an updated meta-analysis of cardiovascular outcome trials Cord-id: agq0wvmy Document date: 2021_6_6
ID: agq0wvmy
Snippet: The present meta-analysis included 8 cardiovascular outcome trials with 57,185 patients at high cardiometabolic risk. In comparison with placebo, treatment with sodium-glucose cotransporter inhibitors was associated with a significantly lower risk of pneumonia (RR 0.85, 95% CI 0.76–0.95, p = 0.004; I(2) = 0, p = 0.48). SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s13340-021-00515-4.
Document: The present meta-analysis included 8 cardiovascular outcome trials with 57,185 patients at high cardiometabolic risk. In comparison with placebo, treatment with sodium-glucose cotransporter inhibitors was associated with a significantly lower risk of pneumonia (RR 0.85, 95% CI 0.76–0.95, p = 0.004; I(2) = 0, p = 0.48). SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s13340-021-00515-4.
Search related documents:
Co phrase search for related documents- Try single phrases listed below for: 1
Co phrase search for related documents, hyperlinks ordered by date